Background illustration for clinical trials search

Lung Cancer Clinical Trials

Browse 2,144 lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

for
Cancer, Liver Cirrhosis, Chronic Hepatitis, Hepatitis B,
Location: Memphis TN, Fridley MN, Minneapolis MN, Coon Rapids MN,
Sponsor: Helio Genomics

Sex: All

Age: 18+

Code: NCT05181826

Recruiting

Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery

for
Cancer
Location: Durham NC
Sponsor: VA Office of Research and Development

Sex: All

Age: 55+

Code: NCT05912257

Recruiting

myCare-102: Clinical Utility and Usability of Cellworks Singula™ and Cellworks Ventura™ Reports

for
Cancer, Relapsed Cancer, Refractory Cancer
Location: Sioux Falls SD
Sponsor: Cellworks Group Inc.

Sex: All

Age: 0+

Code: NCT05693831

Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for
Solid Tumors, Hematologic Malignancies
Location: Quebec, Sherbrooke, White Plains NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT03486873

Phase 3, Recruiting

A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

for
Refractory Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 1 - 25

Code: NCT06006273

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain

for
Cancer, Breakthrough Cancer Pain
Location: Berlin NJ
Sponsor: Tetra Bio-Pharma

Sex: All

Age: 18+

Code: NCT03564548

Phase 2, Recruiting

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

for
Cigarette Smoking-Related Carcinoma
Location: Saint Johnsbury VT, Lebanon NH, New York NY,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT05008848

Phase 3, Recruiting

Study of the Disease Process of Lymphangioleiomyomatosis

for
Lung Disease, Pneumothorax, Tuberous Sclerosis,
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 16 - 70+

Code: NCT00001465

Recruiting

AMT-116 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Dallas TX
Sponsor: Multitude Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT05725291

Phase 1, Recruiting

A Pilot Study of Genetic Testing Uptake Through Enhanced Oncology Nurse-Led Intervention

for
Solid Tumor, Adult
Location: Chico CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT06436157

Recruiting

A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma

for
Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL)
Location: Huntersville NC
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT05569057

Phase 1, Recruiting

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

for
Neoplasms
Location: The Bronx NY, New York NY, East Brunswick NJ,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06150157

Phase 1, Recruiting

UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions

for
Brain Metastases, Adult, Neurocognitive Function, Cancer,
Location: San Diego CA
Sponsor: Jona Hattangadi-Gluth

Sex: All

Age: 18+

Code: NCT04343157

Phase 2, Recruiting

A Non-pharmacological Cough Control Therapy

for
Cough, ILD, Pulmonary Disease, Pulmonary Fibrosis
Location: Toronto, Hamilton
Sponsor: West Park Healthcare Centre

Sex: All

Age: 18 - 70+

Code: NCT04767074

Recruiting

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

for
Advanced Solid Malignancies
Location: Boston MA, New York NY, Chicago IL, Houston TX,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05417594

Phase 1, Phase 2, Recruiting

Phase 2 Study of Fingolimod in Lung Cancers

for
Non Small Cell Lung Cancer, Small-cell Lung Cancer
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT06424067

Phase 2, Recruiting

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

for
Advanced Solid Malignancies
Location: New Brunswick NJ, Richmond VA, Sarasota FL,
Sponsor: Georgiamune Inc

Sex: All

Age: 18+

Code: NCT06028074

Phase 1, Phase 2, Recruiting

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: New York NY, Augusta GA, Grand Rapids MI, Chicago IL,
Sponsor: National Cancer Institute LAO

Sex: All

Age: 0+

Code: NCT02474160

Recruiting

Characterization of Fetal Lung With Quantitative Ultrasound

for
Respiratory Complication, Fetal Lung Imaging
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: Female

Age: 18 - 45

Code: NCT06722365

Recruiting

Pembrolizumab, Ibrutinib and Rituximab in PCNSL

for
Primary Central Nervous System Lymphoma, Recurrent Cancer,
Location: Boston MA, New York NY
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04421560

Phase 1, Phase 2, Recruiting

What is lung cancer?

Lung cancer starts when cells in the airways or lungs grow out of control. About 229,000 Americans will be diagnosed in 2026. There are two main types: non small cell lung cancer, about 85 percent of cases, and small cell lung cancer, which grows and spreads faster and is treated differently. Smoking causes most cases, but 10 to 20 percent happen in people who never smoked, from causes like radon, air pollution, or genetic changes. Most people are diagnosed around age 70.

Two things changed treatment. First, many lung cancers are driven by a single gene change, and pills that target that specific change can control the cancer for years, so tumors are now routinely tested for these changes before treatment starts. Second, immunotherapy works especially well in lung cancer, and some people with advanced disease are alive and well more than five years later. New targeted drugs kept getting approved through 2025, which is why lung cancer has more recruiting trials than any cancer except breast cancer.

Types of lung cancer clinical trials

Who can participate in lung cancer clinical trials?

What causes lung cancer?

Does vaping cause lung cancer?

The stages of lung cancer, and why they matter for trials

How to enroll in a lung cancer clinical trial